» Articles » PMID: 34450627

Benzo[a]pyrene Stimulates MiR-650 Expression to Promote the Pathogenesis of Fatty Liver Disease and Hepatocellular Carcinoma Via SOCS3/JAK/STAT3 Cascades

Overview
Journal J Mol Cell Biol
Specialty Molecular Biology
Date 2021 Aug 27
PMID 34450627
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Modern diets, which often feature high levels of fat and charcoal-grilled meat, contribute to the pathogenesis of obesity and nonalcoholic fatty liver disease (NAFLD), resulting in liver cancer progression. Benzo(a)pyrene (B[a]P) is a common environmental and foodborne pollutant found in smoke and fire-grilled foods, which can have an adverse effect on human health. Hepatocellular carcinoma (HCC) is the fifth leading cause of cancer and the second leading cause of cancer-related deaths worldwide. The epidemiological studies suggest that both environmental risk factors and chronic liver injury including NAFL are important for HCC development, but the precise mechanisms linking eating habits to hepato-carcinogenesis remain unclear. In the present study, we demonstrated that various miRNAs in B[a]P-exposed tumor cells contribute to tumor metastasis, among which miR-650 could be the most potent inducer. Furthermore, we found that suppressor of cytokine signaling 3 (SOCS3) is directly regulated by miR-650 and its suppression regulates the activation of the Janus kinase/signal transducer and activator of transcription 3 (JAK/STAT3) cascade. Our findings reveal a possible adverse outcome pathway of SOCS3/JAK/STAT3 regulation in B[a]P-induced HCC progress. These results provide a better understanding of the adverse effects of chronic exposure to B[a]P on human health.

Citing Articles

Evidence That Peripheral Leptin Resistance in Omental Adipose Tissue and Liver Correlates with MASLD in Humans.

De la Cruz-Color L, Dominguez-Rosales J, Maldonado-Gonzalez M, Ruiz-Madrigal B, Sanchez Munoz M, Zaragoza-Guerra V Int J Mol Sci. 2024; 25(12).

PMID: 38928125 PMC: 11203746. DOI: 10.3390/ijms25126420.


Exposure of benzo[a]pyrene induces HCC exosome-circular RNA to activate lung fibroblasts and trigger organotropic metastasis.

Mu W, Gu P, Li H, Zhou J, Jian Y, Jia W Cancer Commun (Lond). 2024; 44(7):718-738.

PMID: 38840551 PMC: 11260768. DOI: 10.1002/cac2.12574.


Hepatoprotective Effects of Flavonoids against Benzo[a]Pyrene-Induced Oxidative Liver Damage along Its Metabolic Pathways.

Kim M, Jee S, Sung J Antioxidants (Basel). 2024; 13(2).

PMID: 38397778 PMC: 10886006. DOI: 10.3390/antiox13020180.


Regulation of Benzo[a]pyrene-Induced Hepatic Lipid Accumulation through CYP1B1-Induced mTOR-Mediated Lipophagy.

Bu K, Kim M, Shin M, Lee S, Sung J Int J Mol Sci. 2024; 25(2).

PMID: 38279324 PMC: 10816991. DOI: 10.3390/ijms25021324.


Dynamic changes of DNA methylation induced by benzo(a)pyrene in cancer.

Wang H, Liu B, Chen H, Xu P, Xue H, Yuan J Genes Environ. 2023; 45(1):21.

PMID: 37391844 PMC: 10314634. DOI: 10.1186/s41021-023-00278-1.


References
1.
Zhang C, Wang P, Li Y, Huang C, Ni W, Chen Y . Role of MicroRNAs in the Development of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease. Anat Rec (Hoboken). 2018; 302(2):193-200. DOI: 10.1002/ar.23954. View

2.
Shi Z, Dragin N, Miller M, Stringer K, Johansson E, Chen J . Oral benzo[a]pyrene-induced cancer: two distinct types in different target organs depend on the mouse Cyp1 genotype. Int J Cancer. 2010; 127(10):2334-50. PMC: 2917638. DOI: 10.1002/ijc.25222. View

3.
Fu X, Shi Y, Zhou J, Peng Y, Liu W, Shi G . MicroRNA-30a suppresses autophagy-mediated anoikis resistance and metastasis in hepatocellular carcinoma. Cancer Lett. 2017; 412:108-117. DOI: 10.1016/j.canlet.2017.10.012. View

4.
Kershaw N, Murphy J, Liau N, Varghese L, Laktyushin A, Whitlock E . SOCS3 binds specific receptor-JAK complexes to control cytokine signaling by direct kinase inhibition. Nat Struct Mol Biol. 2013; 20(4):469-76. PMC: 3618588. DOI: 10.1038/nsmb.2519. View

5.
Budhu A, Jia H, Forgues M, Liu C, Goldstein D, Lam A . Identification of metastasis-related microRNAs in hepatocellular carcinoma. Hepatology. 2008; 47(3):897-907. DOI: 10.1002/hep.22160. View